Loading market dashboard
PTC Inc.
PTCTechnologyNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?
On June 01, 2026, PTC Inc (PTC) shares rose 4.6% today, closing at $145.08. This move comes amid a 52-week range that has seen a high of $219.69 and a low of $1
New York, May 29, 2026 (GLOBE NEWSWIRE) -- The Insight Partners published its latest market intelligence report on the Global Digital Twin Market. The study finds the market, valued at US$ 13,739. 99 million in 2024, is projected to reach US$ 140,938.
New York, May 29, 2026 (GLOBE NEWSWIRE) -- The Insight Partners published its latest market intelligence report on the Global Digital Twin Market . The study finds the market, valued at US$ 13,739.99 million in 2024, is projected to reach US$ 140,938.14 million by 2031, registering a compound annual growth rate (CAGR) of 40% over the 2025 - 2031 forecast period.
PTC named Official Engine Design Software Partner of TRD Creo CAD and Windchill PLM are designated solutions for design and development of TRD's high-performance engines Creo CAD and Windchill PLM enable advanced engineering capabilities, efficiencies, and speed to market BOSTON, May 28, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it was named the Official Engine Design Software Partner of TRD U.S.A. (Toyota Racing Development).
Mazda selects Codebeamer ALM solution to help strengthen requirements management, improve quality, support compliance, and accelerate innovation for software-defined vehicle development Maintains connectivity to Mazda's advanced Model-Based Development (MBD) Establishes foundation for integrated product development and future AI-enabled workflows BOSTON, May 21, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Mazda Motor Corporation, a leading global automaker, has selected the PTC Codebeamer® Application Lifecycle Management (ALM) solution to support its software-defined vehicle development (SDV). Mazda will use Codebeamer to standardize requirements, testing, and validation, enabling end-to-end traceability and faster product development while meeting automotive standards.
PTC Inc. (PTC) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
Free access to Onshape, Creo+, Codebeamer+, and a startup package for Arena to manage every stage of the product lifecycle from design and development through compliance and launch Annual renewals available to support startups through key funding and revenue milestones Exposure to PTC's global ecosystem to support industry visibility BOSTON , May 13, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the expansion of its startup program to companies across all industries, extending a model that began with its Aerospace and Defense Startup Program, launched in 2025. Building on that program's success, PTC for Startups now makes PTC's professional-grade product development tools available to qualifying early and growth-stage startups worldwide — at no cost.
Connects Printed Circuit Board (PCB) design from Altium directly into Onshape in a unified cloud-native workflow Eliminates file-based PCB data exchange between electrical and mechanical design Streamlines inclusion of detailed components in your personal or company library BOSTON, May 12, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced a new integration between its cloud-native Onshape® computer‑aided design (CAD) and product data management (PDM) platform and Altium. The connector enables electrical and mechanical engineering teams to collaborate more effectively by bringing Printed Circuit Board (PCB) designs directly into Onshape and keeping changes synchronized across both platforms.
PTC Therapeutics is transitioning from a legacy rare disease business to a growth-focused model, anchored by the successful Sephience launch. Sephience's rapid commercial uptake is offsetting DMD franchise declines, with Q1 2026 product revenue up 47% year-over-year and strong patient onboarding momentum. PTCT's partnership with Novartis on votoplam for Huntington's disease offers de-risked late-stage upside, while a $1.9B cash position provides strategic flexibility and reduces near-term dilution risk.
PTC Therapeutics NASDAQ: PTCT reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or PKU.
– First quarter 2026 total revenue of $273 million, including $226 million of product revenue, supporting full-year 2026 guidance raise – – Global Sephience™ (sepiapterin) launch momentum continues with first quarter 2026 revenue of $125 million, representing 36% quarter-over-quarter growth – – Positive topline results from 24-month interim analysis of PIVOT-HD extension study of votoplam, supporting ongoing global Phase 3 INVEST-HD study and potential regulatory interactions – – Open-label vatiquinone registration study to be initiated in Q3 2026 based on FDA feedback – WARREN, N.J., May 7, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ended March 31, 2026.
PTC jumped in pre-market trading after fiscal Q2 2026 revenue rose 22% and AI-driven product demand fueled stronger ARR growth and buybacks.
PTC shares jumped 7.53% in after-hours trading after the company beat Q2 fiscal 2026 revenue estimates by 8.63% and EPS expectations by 33.83%.
PTC Inc. (PTC) Q2 2026 Earnings Call Transcript
While the top- and bottom-line numbers for PTC Inc. (PTC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
PTC Inc. (PTC) came out with quarterly earnings of $2.69 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $1.79 per share a year ago.
PTC Inc on Wednesday raised its full-year revenue forecast, citing continued demand from manufacturers using its software to digitize their design and production processes.
Strategic focus on Intelligent Product Lifecycle vision Solid execution in Q2'26 Constant currency ARR growth of 8.5% excluding divested businesses Operating and free cash flow growth of 14% ~$625 million of cash used for repurchases in Q2'26; targeting repurchases of ~$1.225 billion to ~$1.325 billion in FY'26; New $2 billion share repurchase authorization effective for FY'27-FY'28. BOSTON, May 6, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its second fiscal quarter ended March 31, 2026.
Windchill enables enterprise-scale digital engineering from acquisition to sustainment Streamlines governance and supports modernization, increases availability of essential mission-critical data Allows for identification of cost-reduction opportunities BOSTON, May 6, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the U.S. Army has designated the Windchill® product lifecycle management (PLM) solution as its official Product Data Management (PDM) and Product Lifecycle Management (PLM) platform. The U.S. Army, through a DEVCOM‑led initiative, is advancing a modern PLM environment to improve the management, governance, and reuse of authoritative product data across the Army enterprise.
PTC heads into Q2 earnings with double-digit revenue and EPS growth expectations, strong ARR momentum and expanding AI-driven product capabilities.
Collaboration agreement formed to advance market-specific ALM-PLM solutions Codebeamer ALM solution selected to enhance collaboration, validation, traceability, and regulatory compliance across product development workflows Multi-year collaboration aims to advance PTC's ALM and PLM market-specific capabilities BOSTON, May 5, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Hamilton Medical, a global leader in intelligent mechanical ventilation solutions, selected PTC's Codebeamer® Application Lifecycle Management (ALM) solution to replace its legacy ALM system and paper-based processes. Further, PTC and Hamilton Medical, a long-term user of PTC's Windchill® Product Lifecycle Management (PLM) solution, have agreed to collaborate to strengthen mutual outcomes.
WARREN, N.J., May 4, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Bank of America Securities Health Care Conference 2026 Tuesday, May 12 at 8:40 a.m.
PTC Therapeutics Inc. (NASDAQ:PTCT) shares are tumbling on Wednesday, after the company reported topline results from the 24-month interim analysis of its PIVOT-HD long-term extension study.
- Dose-dependent benefit on cUHDRS in Stage 2 participants compared to matched natural history cohort, with 52% slowing at 10 mg dose - - Continued evidence of favorable safety profile - - Novartis initiated global Phase 3 INVEST-HD study of votoplam - - PTC will host a conference call to discuss results today, April 28, at 4:30 pm ET - WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today reported positive topline results from the 24-month interim analysis of the PIVOT-HD long-term extension study, with favorable dose-dependent effects on disease progression for Stage 2 Huntington's disease (HD) patients following 24 months of votoplam treatment compared to an external natural history cohort.
WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m.
Allows users to ask questions in natural language to quickly find answers through an embedded chat interface Helps teams save time by summarizing and surfacing key details from product documents Applies AI to existing Windchill data while maintaining security and access controls BOSTON, April 28, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the release of Windchill AI Assistant, a new artificial intelligence (AI) capability built in its Windchill® product lifecycle management (PLM) solution. This new capability introduces generative AI into Windchill via a natural language chat interface, making it easier for users to find, understand, and work with critical product information already stored in the platform, reducing time spent searching and enabling increases in team productivity.
MUNICH, April 22, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) PTC today announced it will demonstrate how Bobcat, a leading global manufacturer of compact equipment, can leverage the Intelligent Product Lifecycle to improve the development process of an excavator at Hannover Messe (HM) 2026. By creating a centralized product data foundation that connects design, engineering, and operations and enables AI-driven transformation, Bobcat can reduce time, errors, and rework across highly complex products and processes.
WARREN, N.J., April 22, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, May 7, 2026, at 4:30 p.m.
Massachusetts Financial Services Co. MA reduced its position in shares of PTC Inc. (NASDAQ: PTC) by 98.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,770 shares of the technology company's stock after selling 167,910 shares during the
WARREN, N.J., April 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 13, 2026, the company approved non-statutory stock options to purchase an aggregate of 1,155 shares of its common stock and 925 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to a new non-executive employee.
Argo Wealth Advisory LLC bought a new position in shares of PTC Inc. (NASDAQ: PTC) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 14,210 shares of the technology company's stock, valued at approximately $2,476,000. PTC accounts for about 1.5% of Argo Wealth
BOSTON, April 13, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) will release its fiscal 2026 second quarter results and on Wednesday, May 6th after the stock market closes. Senior management will host a live webcast and conference call to review the results on Wednesday, May 6th at 5 pm Eastern Time.
CCLA Investment Management trimmed its position in PTC Inc. (NASDAQ: PTC) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 674,102 shares of the technology company's stock after selling 12,779 shares during the quarter. PTC comprises approximately 1.9% of
SG Americas Securities LLC lessened its stake in PTC Inc. (NASDAQ: PTC) by 69.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,782 shares of the technology company's stock after selling 35,215 shares during the period. SG Americas Securities LLC's
PTC's Codebeamer becomes BMW's core engineering platform, unifying data and advancing AI-driven workflows as the company accelerates its intelligent lifecycle vision.
Codebeamer becomes standard for requirements management at BMW Group Provides a unified foundation for integrated product development BOSTON, April 1, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that BMW Group, a global leader in premium automotive innovation, has successfully implemented PTC's Codebeamer® application lifecycle management (ALM) solution as the foundation for its next generation of digital engineering. This milestone reflects BMW's move from fragmented legacy requirements management systems across hundreds of systems to a single unified data model within Codebeamer.
WARREN, N.J., March 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the appointment of Jessica Chutter to its Board of Directors.
Contravisory Investment Management Inc. purchased a new stake in shares of PTC Inc. (NASDAQ: PTC) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 4,670 shares of the technology company's stock, valued at approximately $814,000. Several other institutional investors have also modified their
PTC (NASDAQ: PTC) used an investor update call to discuss the completed divestiture of its Kepware and ThingWorx businesses and to outline how the transaction affects fiscal 2026 guidance, cash flow expectations, and capital allocation priorities. Chief Financial Officer Jen D'Errico said the company is "pleased to complete the divestiture" and will increase its focus on
PTC connects Onshape CAD directly to NVIDIA Isaac Sim in a cloud-native workflow Helps robotics teams move from design to realistic simulation in minutes, while maintaining a single source of truth Delivers simulation-ready robot designs that update automatically as designs change BOSTON, March 17, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced a new robotics design-to-simulation workflow that connects PTC's cloud-native Onshape® computer-aided design (CAD) and product data management (PDM) platform with NVIDIA Isaac Sim open simulation framework. The workflow is being introduced at NVIDIA GTC 2026 to demonstrate how teams can simulate robot designs while maintaining a single source of truth, enabling time savings, reduced errors, and accelerated development, while also supporting physical AI through downstream robotic training in NVIDIA Isaac Lab.
PTC Inc. (PTC) Discusses Divestiture of Kepware and ThingWorx and Provides Updated Financial Guidance Transcript
Divestiture of Kepware Industrial Connectivity and ThingWorx IoT businesses enables PTC to increase focus on Intelligent Product Lifecycle vision Updating post-divestiture financial guidance for FY'26 and Q2'26 Net after-tax proceeds from the divestiture will be used for share repurchases; Announcing $375 million accelerated share repurchase program BOSTON, March 16, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced it has completed the previously announced sale of the company's Kepware® industrial connectivity and ThingWorx® Internet of Things (IoT) businesses to TPG, a leading global alternative asset management firm. "We are pleased to complete the divestiture of our Kepware and ThingWorx businesses as we increase our focus on our Intelligent Product Lifecycle vision," said Neil Barua, President and CEO, PTC.
Aquatic Capital Management LLC bought a new stake in PTC Inc. (NASDAQ: PTC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 45,354 shares of the technology company's stock, valued at approximately $9,208,000. Other institutional investors and
WARREN, N.J., March 13, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 10, 2026, the company approved non-statutory stock options to purchase an aggregate of 14,550 shares of its common stock and 17,515 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 18 new employees.
PTC is now embedding AI into its solutions, promising greater efficacy. The company continues to grow its recurring revenue at an impressive rate, and its valuation is at a multiyear low.
